INHIBITION OF BASAL AND MITOGEN-STIMULATED PANCREATIC-CANCER CELL-GROWTH BY CYCLIN D1 ANTISENSE IS ASSOCIATED WITH LOSS OF TUMORIGENICITY AND POTENTIATION OF CYTOTOXICITY TO CISPLATINUM

Citation
M. Kornmann et al., INHIBITION OF BASAL AND MITOGEN-STIMULATED PANCREATIC-CANCER CELL-GROWTH BY CYCLIN D1 ANTISENSE IS ASSOCIATED WITH LOSS OF TUMORIGENICITY AND POTENTIATION OF CYTOTOXICITY TO CISPLATINUM, The Journal of clinical investigation, 101(2), 1998, pp. 344-352
Citations number
52
Categorie Soggetti
Medicine, Research & Experimental
ISSN journal
00219738
Volume
101
Issue
2
Year of publication
1998
Pages
344 - 352
Database
ISI
SICI code
0021-9738(1998)101:2<344:IOBAMP>2.0.ZU;2-1
Abstract
Cyclin D1 belongs to a family of protein kinases that have been implic ated in cell cycle regulation. Recent studies have demonstrated that e levated cyclin D1 levels correlate with decreased survival in human pa ncreatic cancer. In this study we expressed in a stable manner a cycli n D1 antisense cDNA construct in PANC-1 human pancreatic cancer cells, Expression of the antisense construct caused a decrease in cyclin D1 mRNA and protein levels and in cyclin D1-associated kinase activity. A ntisense expressing clones displayed significantly increased doubling times, decreased anchorage-dependent and -independent basal growth, an d complete loss of tumorigenicity in nude mice. EGF, FGF-2, and IGF-I enhanced mitogen-activated protein kinase activity in antisense expres sing clones, but failed to stimulate their proliferation. In contrast, all three growth factors were mitogenic in parental cells. Furthermor e, the inhibitory effect of cisplatinum on cell proliferation was enha nced markedly in the antisense expressing clones. These findings indic ate that cyclin D1 overexpression contributes to abnormal growth and t umorigenicity in human pancreatic cancer and to the resistance of panc reatic cancer to chemotherapeutic agents.